Issue #5 2014 – Digital edition

Posted: 5 November 2014 |

In this issue: Protein Characterisation, RMM, Flow Cytometry, Spray drying, NMR spectroscopy, Raman, Pharmaceutical salts, Sterile Control Strategies and much more…

European Pharmaceutical Review - Issue 5 2014
  • Foreword: Crystallography: A Core Science?
    David Elder, GlaxoSmithKline and JPAG
  • Protein Characterisation: A history of recombinant protein technology in small molecule drug discovery
    Rick Davies, Associate Director, AstraZeneca; Ian Hardern, Senior Research Scientist, AstraZeneca; Ross Overman, Associate Principle Scientist, AstraZeneca
  • In-Depth Focus: RMM
    Featuring articles from Michael J. Miller, President of Microbiology Consultants, and Deborah Gessell-Lee (Baxter), Oliver Gordon (Novartis), Joe Johnston (Fresenius), Neil Lewis (Procter & Gamble), Jeanne Mateffy (Amgen) and Jeffrey W. Weber (Pfizer). Plus an RMM Roundtable, moderated by James L. Drinkwater of F Ziel.
  • Flow Cytometry: Flow cytometry for the optimisation of microbial recombinant protein production
    Tim W. Overton, University of Birmingham
  • Spray Drying: Spray drying in the pharmaceutical industry
    Filipe Gaspar, Senior Director of Particle Engineering Services, Hovione
  • NMR Spectroscopy: a superior tool for quality control of pharmaceutical products
    Torgny Rundlöf, Pharmaceutical Evaluator, Medical Products Agency, Sweden
  • In-Depth Focus: Raman
    Featuring articles from Sulaf Assi of Bournemouth University and University of Liege Scientists Lauranne Netchacovitch, Charlotte De Bleye, Pierre-François Chavez, Pierre-Yves Sacré, Philippe Hubert and Eric Ziemons. Plus a Roundtable on Raman hosted by Bradley Diehl of Pfizer.
  • Pharmaceutical Salts: Pharmaceutical salts of small molecule drugs – opportunities and challenges
    Axel Becker, Merck KGaA
  • Sterile Control Strategies: The need for control strategies in the manufacturing of sterile pharmaceutical products
    James L. Drinkwater, F Ziel

The digital version of Issue #5 2014 is restricted - login or subscribe free to access

European Pharmaceutical Review Issue 4 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here